Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ABI-008 Trial in Patients With Metastatic Breast Cancer

This study has been terminated.
Information provided by:
Celgene Corporation Identifier:
First received: September 14, 2007
Last updated: June 11, 2009
Last verified: June 2009
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2008
  Estimated Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)